Journal of Kerman University of Medical Sciences

Current Issue

By Issue

By Author

Author Index

Keyword Index

About Journal

Aims and Scope

JKMU Ethical Policies

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

News

Metric

Editorial Policies

Data Sharing Policy

Oral and Laryngeal Diadochokinetic Rate in Multiple Sclerosis: Relationship to Disease Progression

Document Type : Original Article

Authors

1 Musculoskeletal Rehabilitation Research Center, Speech Therapy Department, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

2 Assistant Professor, Musculoskeletal Rehabilitation Research Center, Speech Therapy Department, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

3 University Lecturer, Musculoskeletal Rehabilitation Research Center, Speech Therapy Department, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

4 Health Research Institute, Diabetes Research center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

5 Assistant Professor, Department of Neurology, Golestan Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Abstract

Background: The first purpose of this study was to investigate the rate of oral and laryngeal Diadochokinesis (DDK) in Multiple Sclerosis (MS) patients in comparison with healthy people. The second goal was to determine if DDK rate has any relationship with the disease progression.
Methods: In this cross-sectional study, two groups were enrolled: MS patients (n=31) and healthy subjects (n=14) . The samples of DDK tasks were collected. The scores of Expanded Disability Status Scale (EDSS) and duration of disease were considered as the indices of disease progression.
Results: There were significant differences between the two groups in the rates of all DDK tasks (P≤0.001). Significant correlations were found between laryngeal DDK tasks and disease progression (r = - 0.488, r = -0.396, r = -0.444, r = - 0.667, P ≤ 0.027). Two oral DDK tasks were in correlation with EDSS and the disease duration (r = -0.403, r = -0.446, r =-0.521, r = -0.465, p≤0.025). There were high correlations between functional systems of EDSS (pyramidal, cerebellar and brainstem) and DDK tasks (r = - 0.448, r = -452, r = -0.458, r =-0.379, P ≤ 0.036).
Conclusions: In the present study, poor performance in DDK tasks provided evidence for insufficient motor control over related speech subsystems in MS. These findings suggest that DDK rate is a sensitive beneficial speech motor control assessment in MS. Moreover, DDK tasks might be introduced as additional prognostic parameters for detecting disease progression and evaluating treatment achievements.

Keywords

References
  1. Kent RD. Research on speech motor control and its disorders: A review and prospective. Journal of Communication disorders. 2000;33(5):391-428.
  2. Bhat JS. Oral Diadokokinetic rate-An insight into speech motor control. International Journal of Advanced Speech and Hearing Research. 2012;1(1):pp. 10-4.
  3. Freed D. Motor Speech Disorders: Diagnosis & Treatment: Nelson Education; 2011.
  4. Green JR, Yunusova Y, Kuruvilla MS, Wang J, Pattee GL, Synhorst L, et al. Bulbar and speech motor assessment in ALS: Challenges and future directions. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2013;14(7-8):494-500.
  5. Ziegler W. Task-related factors in oral motor control: Speech and oral diadochokinesis in dysarthria and apraxia of speech. Brain and Language. 2002;80(3):556-75.
  6. Icht M, Ben-David BM. Oral-diadochokinesis rates across languages: English and Hebrew norms. Journal of Communication Disorders. 2014;48:27-37.
  7. Duffy JR. Motor Speech Disorders-E-Book: Substrates, Differential Diagnosis, and Management: Elsevier Health Sciences; 2013.
  8. Tjaden K, Watling E. Characteristics of diadochokinesis in multiple sclerosis and Parkinson’s disease. Folia Phoniatrica et Logopaedica. 2003;55(5):241-59.
  9. Ergun A, Oder W. Oral diadochokinesis and velocity of narrative speech: a prognostic parameter for the outcome of diffuse axonal injury in severe head trauma. Brain injury. 2008;22(10):773-9.
  10. Maturo S, Hill C, Bunting G, Ballif C, Maurer R, Hartnick C. Pediatric laryngeal diadochokinetic rates: establishing a normative database. Otolaryngology--Head and Neck Surgery. 2012;146(2):302-6.
  11. Renout KA, Leeper HA, Bandur DL, Hudson AJ. Vocal fold diadochokinetic function of individuals with amyotrophic lateral sclerosis. American Journal of Speech-Language Pathology. 1995;4(1):73-80.
  12. Wang Yt, Kent RD, Duffy JR, Thomas JE, Weismer G. Alternating motion rate as an index of speech motor disorder in traumatic brain injury. Clinical Linguistics & Phonetics. 2004;18(1):57-84.
  13. Riecker A, Kassubek J, Gröschel K, Grodd W, Ackermann H. The cerebral control of speech tempo: Opposite relationship between speaking rate and BOLD signal changes at striatal and cerebellar structures. NeuroImage. 2006;29(1):46-53.
  14. Silbergleit AK, LeWitt PA, Peterson EL, Gardner GM. Quantitative analysis of voice in Parkinson Disease compared to motor performance: a pilot study. Journal of Parkinson's Disease. 2015;5(3):517-24.
  15. P Z, H R, NT G. Meaningful Words and Non-Words Repetitive Articulatory Rate (Oral Diadochokinesis) in Persian Speaking Children. J Psycholinguist Res. 2016;9(6):96-102.
  16. Klefbeck B, Nedjad JH. Effect of inspiratory muscle training in patients with multiple sclerosis. Archives of physical medicine and rehabilitation. 2003;84(7):994-9.
  17. Webb W, Adler RK. Neurology for the speech-language pathologist: Elsevier Health Sciences; 2016.
  18. Konstantopoulos K, Charalambous M, Verhoeven J, editors. Sequential motion rates in the dysarthria of multiple sclerosis: A temporal analysis. Proceedings of the 17th International Congress of Phonetic Sciences; 2011.
  19. Bauer V, Aleric Z, Jancic E, Knezevic B, Prpic D, Kacavenda A. Subjective and perceptual analysis of voice quality and relationship with neurological disfunction in multiple sclerosis patients. Clinical neurology and neurosurgery. 2013;115:S17-S20.
  20. Hartelius L, Runmarker B, rn o, Andersen O. Prevalence and characteristics of dysarthria in a multiple-sclerosis incidence cohort: relation to neurological data. Folia phoniatrica et logopaedica. 2000;52(4):160-77.
  21. Yamout B, Fuleihan N, Hajj T, Sibai A, Sabra O, Rifai H, et al. Vocal symptoms and acoustic changes in relation to the expanded disability status scale, duration and stage of disease in patients with multiple sclerosis. European Archives of Oto-Rhino-Laryngology. 2009;266(11):1759-65.
  22. Smith MM, Arnett PA. Dysarthria predicts poorer performance on cognitive tasks requiring a speeded oral response in an MS population. Journal of clinical and experimental neuropsychology. 2007;29(8):804-12.
  23. Kurtzke JF. Rating neurologic impairment in multiple sclerosis an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444-.
  24. Farzianpour F, Farokhi B, Shojaei S, Shafii M, Manafi F. Status of the elderly healthcare costs. American Journal of Agricultural and Biological Sciences. 2014;9(2):194.
  25. Arnett JJ. Emerging adulthood: A theory of development from the late teens through the twenties. American psychologist. 2000;55(5):469.
  26. Roy N, Barton ME, Smith ME, Dromey C, Merrill RM, Sauder C. An in vivo model of external superior laryngeal nerve paralysis. The Laryngoscope. 2009;119(5):1017-32.
  27. Wang Y-T, Kent RD, Duffy JR, Thomas JE. Analysis of diadochokinesis in ataxic dysarthria using the motor speech profile program™. Folia Phoniatrica et Logopaedica. 2009;61(1):1-11.
  28. Gadesmann M, Miller N. Reliability of speech diadochokinetic test measurement. International Journal of Language & Communication Disorders. 2008;43(1):41-54.
  29. Boersma PPG. Praat, a system for doing phonetics by computer. Glot international. 2002;5.
  30. Fridriksson J, Guo D, Fillmore P, Holland A, Rorden C. Damage to the anterior arcuate fasciculus predicts non-fluent speech production in aphasia. Brain. 2013;136(11):3451-60.
  31. Geurts JJ, Barkhof F. Grey matter pathology in multiple sclerosis. The Lancet Neurology. 2008;7(9):841-51.
  32. Kutzelnigg A, Lassmann H. Cortical demyelination in multiple sclerosis: a substrate for cognitive deficits? Journal of the neurological sciences. 2006;245(1):123-6.
  33. Gilmore CP, Donaldson I, Bö L, Owens T, Lowe J, Evangelou N. Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord. Journal of Neurology, Neurosurgery & Psychiatry. 2009;80(2):182-7.
  34. Natour Y, Marie B, Aljunidy L. The respiratory muscle capabilities of Jordanian patients with multiple sclerosis. Journal of Voice. 2012;26(6):811. e15-. e18.
  35. Ray AD, Mahoney MC, Fisher NM. Measures of respiratory function correlate with fatigue in ambulatory persons with multiple sclerosis. Disability and rehabilitation. 2015;37(26):2407-12.
  36. Gerald FJF, Murdoch BE, Chenery HJ. Multiple sclerosis: Associated speech and language disorders. Australian Journal of Human Communication Disorders. 1987;15(2):15-35.
  37. Darley FL, Brown JR, Goldstein NP. Dysarthria in multiple sclerosis. Journal of Speech, Language, and Hearing Research. 1972;15(2):229-45.
  38. Nogués MA, Roncoroni AJ, Benarroch E. Breathing control in neurological diseases. Clinical Autonomic Research. 2002;12(6):440-9.

 

Journal of Kerman University of Medical Sciences
Volume 25, Issue 2
March and April 2018
Pages 164-174
Files
Share
How to cite
Statistics